Select Bibliography

Filter by any of these (after searching):

NCCTG-N9943

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 2 items

Pemetrexed and gemcitabine for biliary tract and gallbladder carcinomas: a North Central Cancer Treatment Group (NCCTG) phase I and II Trial, N9943.

Alberts, Steven R , Sande, Jonathan R , Foster, Nathan R ... - - J Gastrointest Cancer - 2007

Manuscript - Primary - Primary - GI - NCCTG-N9943

NCCTG phase I/II trial (N9943) of gemcitabine and pemetrexed in patients with biliary tract or gallbladder carcinoma: phase II results

Mcwilliams, R. R. , Foster, N. R. , Quevedo, F. J. , Marschke, R. F. ... - - J Clin Oncol - 2007

Abstract - Primary - Primary - GI - NCCTG-N9943